{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:27:56Z","timestamp":1787110076414,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172692"],"award-info":[{"award-number":["82172692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105502","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:50:48Z","timestamp":1785073848000},"page":"105502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era"],"prefix":"10.1016","volume":"225","author":[{"given":"Jinghan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-4596","authenticated-orcid":false,"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105502_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2020.00531","article-title":"Tumor-derived extracellular vesicles impair CD171-Specific CD4+ CAR T Cell Efficacy","volume":"11","author":"Ali","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308131","article-title":"Tumor exosomal ENPP1 hydrolyzes cGAMP to Inhibit cGAS-STING signaling","volume":"11","author":"An","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105502_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2019.06.021","article-title":"Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study","volume":"120","author":"Bar","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105502_bib5","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.critrevonc.2026.105502_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jtha.2024.03.021","article-title":"A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy","volume":"22","author":"Bindal","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib7","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.3390\/cancers14194748","article-title":"High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study","volume":"14","author":"Brocco","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105502_bib8","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T cells and T-cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105502_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/cancers16020450","article-title":"Lung Cancer Related Thrombosis (LCART): focus on immune checkpoint blockade","volume":"16","author":"Charpidou","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105502_bib10","doi-asserted-by":"crossref","first-page":"H1181","DOI":"10.1152\/ajpheart.00579.2020","article-title":"Extracellular vesicles: new players in regulating vascular barrier function","volume":"319","author":"Chatterjee","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105502_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib13","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1016\/j.celrep.2019.05.008","article-title":"Molecular profiling and functional analysis of macrophage-derived tumor extracellular vesicles","volume":"27","author":"Cianciaruso","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105502_bib14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fimmu.2020.01214","article-title":"microRNAs shape myeloid cell-mediated resistance to cancer immunotherapy","volume":"11","author":"Daveri","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","article-title":"Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation","volume":"6","author":"Davila","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-024-02997-x","article-title":"Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC","volume":"43","author":"de Miguel\u2011Perez","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13046-022-02379-1","article-title":"Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer","volume":"41","author":"de Miguel-Perez","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3324\/haematol.2018.197814","article-title":"Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome","volume":"103","author":"De Stefano","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2026.105502_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2021.06.018","article-title":"Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: a retrospective multicentric cohort study","volume":"205","author":"Desch\u00eanes-Simard","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib20","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1093\/eurheartj\/ehab618","article-title":"Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis","volume":"42","author":"Dolladille","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.critrevonc.2026.105502_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102359","article-title":"Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival","volume":"8","author":"Doubre","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib22","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.critrevonc.2026.105502_bib23","first-page":"4434","article-title":"Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells","volume":"43","author":"Dvorak","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3390\/cancers13092260","article-title":"Alterations of the platelet proteome in lung cancer: accelerated F13A1 and ER processing as new actors in hypercoagulability","volume":"13","author":"Ercan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105502_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.2020005710","article-title":"Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model","volume":"137","author":"Feinauer","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib27","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2014-08-531582","article-title":"Platelets at the interface of thrombosis, inflammation, and cancer","volume":"126","author":"Franco","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2021.09.010","article-title":"Immune checkpoint inhibitors for cancer and venous thromboembolic events","volume":"158","author":"Gong","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105502_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw8405","article-title":"Myeloid cell-synthesized coagulation factor X dampens antitumor immunity","volume":"4","author":"Graf","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib32","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/eurheartj\/ehab171","article-title":"Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis","volume":"42","author":"Grilz","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.critrevonc.2026.105502_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.it.2019.04.009","article-title":"Partners in crime: neutrophil-CTC collusion in metastasis","volume":"40","author":"Guo","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105502_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1083\/jcb.201212113","article-title":"Exosomes: looking back three decades and into the future","volume":"200","author":"Harding","year":"2013","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105502_bib37","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/bloodadvances.2020002060","article-title":"Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma","volume":"4","author":"Hashmi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105502_bib38","article-title":"Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy","volume":"4","author":"Heidegger","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2021.10.014","article-title":"Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy","volume":"208","author":"Hill","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib40","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","article-title":"Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer","volume":"12","author":"Hinterleitner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105502_bib41","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jth.13809","article-title":"Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size","volume":"15","author":"Hisada","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib42","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/cancers13153839","article-title":"Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer","volume":"13","author":"Hisada","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105502_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOH.0000000000000521","article-title":"Cancer cell-derived tissue factor positive extracellular vesicles: biomarkers of thrombosis and survival","volume":"26","author":"Hisada","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105502_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12672-025-02195-x","article-title":"Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs","volume":"16","author":"Hu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/biomedicines11030801","article-title":"Exosomal MicroRNA levels associated with immune checkpoint inhibitor therapy in clear cell renal cell carcinoma","volume":"11","author":"Ivanova","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105502_bib48","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1182\/bloodadvances.2021004716","article-title":"Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy","volume":"5","author":"Johnsrud","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105502_bib49","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e41","article-title":"Cerebral infarction caused by Trousseau syndrome associated with cervical cancer","volume":"35","author":"Kanno","year":"2024","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib50","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ejh.13598","article-title":"Prognostic impact and risk factors of cancer-associated thrombosis events in stage-IV cancer patients treated with immune checkpoint inhibitors","volume":"106","author":"Kewan","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib51","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1538-7836.2003.00501.x","article-title":"Malignancy, thrombosis and Trousseau: the case for an eponym","volume":"1","author":"Khorana","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib53","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib54","first-page":"1","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105502_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","article-title":"Mechanisms and biomarkers of cancer-associated thrombosis","volume":"225","author":"Kim","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib56","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s12276-022-00898-7","article-title":"Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib57","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI117202","article-title":"Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors","volume":"93","author":"Kirchhofer","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105502_bib58","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","article-title":"Network-based machine learning approach to predict immunotherapy response in cancer patients","volume":"13","author":"Kong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105502_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjms.2018.11.017","article-title":"Hepatotoxicity and Recurrent NSTEMI While on Pembrolizumab for Metastatic Giant Cell Bone Tumor","volume":"357","author":"Kwan","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105502_bib60","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood.2019004119","article-title":"Platelets and extracellular vesicles and their cross talk with cancer","volume":"137","author":"Lazar","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib61","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1055\/s-0043-1769609","article-title":"Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor","volume":"123","author":"le S\u00e8ve","year":"2023","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib62","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1038\/s41598-017-06893-7","article-title":"Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis","volume":"7","author":"Leal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105502_bib63","doi-asserted-by":"crossref","unstructured":"Lee, J., Kim, D., Kong, J., Ha, D., Kim, I., Park, M., Lee, K., Im, S.-H., Kim, S., n.d. Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors. Sci Adv 10, eadj0785. https:\/\/doi.org\/10.1126\/sciadv.adj0785.","DOI":"10.1126\/sciadv.adj0785"},{"key":"10.1016\/j.critrevonc.2026.105502_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib65","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib66","first-page":"4498","article-title":"Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK\/T-cell lymphoma, nasal-type","volume":"10","author":"Li","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib67","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","article-title":"Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer","volume":"54","author":"Li","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib68","article-title":"PD-L1 regulates platelet activation and thrombosis via caspase-3\/GSDME Pathway","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112886","article-title":"Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo","volume":"409","author":"Liu","year":"2021","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1027472","article-title":"The exosomes in tumor immunity","volume":"4","author":"Liu","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105502_bib71","article-title":"Exosomal PD-L1 in cancer and other fields: recent advances and perspectives","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib72","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor microenvironment-derived exosomes: a double-edged sword for advanced T Cell-Based Immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105502_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105502_bib74","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/cancers11101511","article-title":"Tumor endothelial heterogeneity in cancer progression","volume":"11","author":"Maishi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105502_bib75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.13951","article-title":"Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients","volume":"16","author":"Mauracher","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib76","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.thromres.2022.01.006","article-title":"Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy","volume":"213","author":"McCrae","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib77","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/10428194.2022.2030475","article-title":"Incidence of thrombosis in relapsed\/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience","volume":"63","author":"Melody","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2026.105502_bib78","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood.2020007878","article-title":"Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy","volume":"137","author":"Moik","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2020.12.016","article-title":"Challenging anticoagulation cases: cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management","volume":"199","author":"Moik","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib80","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/rth2.12359","article-title":"Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Moik","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib81","first-page":"205","article-title":"Arterial thromboembolism in cancer patients: a Danish population-based cohort study","volume":"3","author":"Mulder","year":"2021","journal-title":"A Dan. Popul. -Based Cohort Study JACC CardioOncol"},{"key":"10.1016\/j.critrevonc.2026.105502_bib82","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s44161-025-00713-2","article-title":"Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis","author":"Mulholland","year":"2025","journal-title":"Nat. Cardiovasc. Res. 129"},{"key":"10.1016\/j.critrevonc.2026.105502_bib84","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jth.14759","article-title":"Cytokine and chemokine regulation of venous thromboembolism","volume":"18","author":"Najem","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019373","article-title":"Acute hospital mortality of venous thromboembolism in patients with cancer from registry data","volume":"10","author":"Okushi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.critrevonc.2026.105502_bib86","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.amjcard.2020.02.016","article-title":"Cardiovascular health and outcomes in cancer patients receiving immune checkpoint inhibitors","volume":"125","author":"Oren","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib87","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/ijms23042321","article-title":"Platelet-released factors: their role in viral disease and applications for extracellular vesicle (EV) Therapy","volume":"23","author":"Ostermeier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105502_bib88","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3390\/cancers14081969","article-title":"Message in a bottle: endothelial cell regulation by extracellular vesicles","volume":"14","author":"Palazzo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105502_bib89","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105502_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/ATVBAHA.120.314644","article-title":"Platelet extracellular vesicles: beyond the blood","volume":"41","author":"Puhm","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib91","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib92","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jth.13612","article-title":"Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent","volume":"15","author":"Reddel","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2026.105502_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1586892","article-title":"Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects","volume":"16","author":"Redkin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib94","doi-asserted-by":"crossref","first-page":"27460","DOI":"10.18632\/oncotarget.25446","article-title":"PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy","volume":"9","author":"Rolfes","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105502_bib95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.medj.2021.02.002","article-title":"Increased incidence of venous thromboembolism with cancer immunotherapy","volume":"2","author":"Roopkumar","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.critrevonc.2026.105502_bib96","first-page":"188","article-title":"Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2","author":"S","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105502_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2020.100020","article-title":"Role of tissue-factor bearing extracellular vesicles released from ovarian cancer cells in platelet aggregation in vitro and venous thrombosis in mice","volume":"2","author":"Sasano","year":"2021","journal-title":"Thromb. Update"},{"key":"10.1016\/j.critrevonc.2026.105502_bib98","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.3390\/ijms232112772","article-title":"Platelets and Their Role in Hemostasis and Thrombosis\u2014From Physiology to Pathophysiology and Therapeutic Implications","volume":"23","author":"Scridon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105502_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biology14010027","article-title":"The role of exosomes in cancer progression and therapy","volume":"14","author":"Sergazy","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.critrevonc.2026.105502_bib100","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.3390\/ijms22189701","article-title":"Characterization and therapeutic use of extracellular vesicles derived from platelets","volume":"22","author":"Spakova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105502_bib101","doi-asserted-by":"crossref","unstructured":"Su, X., Brassard, A., Bartolomucci, A., Dhoparee-Doomah, I., Qiu, Q., Tsering, T., Rohanizadeh, R., Koufos, O., Giannias, B., Bourdeau, F., Feng, L., Messina-Pacheco, J., Leo, S., Sangwan, V., Quail, D., Tankel, J., Spicer, J., Burnier, J.V., Bailey, S.D., Ferri, L., Cools-Lartigue, J., n.d. Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis. https:\/\/doi.org\/10.1002\/jev2.12341.","DOI":"10.1002\/jev2.12341"},{"key":"10.1016\/j.critrevonc.2026.105502_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001719","article-title":"Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival","volume":"9","author":"Sussman","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105502_bib103","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2026.105502_bib104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.20517\/cdr.2022.38","article-title":"Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance","volume":"5","author":"To","year":"2022","journal-title":"Cancer Drug. Resist."},{"key":"10.1016\/j.critrevonc.2026.105502_bib105","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/s41598-017-03262-2","article-title":"Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin","volume":"7","author":"Tripisciano","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105502_bib106","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/jcm9020436","article-title":"Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes","volume":"9","author":"Tschuschke","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib107","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcancer.2024.04.002","article-title":"Comparative analysis of the minimal information for studies of extracellular vesicles guidelines: advancements and implications for extracellular vesicle research","volume":"101","author":"Vaiaki","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib108","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.3390\/cancers13184537","article-title":"Tumor-derived exosomes: hidden players in PD-1\/PD-L1 Resistance","volume":"13","author":"Vautrot","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105502_bib109","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/bloodadvances.2025016044","article-title":"Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies","volume":"9","author":"Vladi\u0107","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105502_bib110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib111","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.1021\/acsnano.1c03517","article-title":"Apoptotic extracellular vesicles ameliorate multiple myeloma by restoring fas-mediated apoptosis","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105502_bib112","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010603","article-title":"Utilization of exosome-based therapies to augment anti-PD-1\/PD-L1 therapies","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105502_bib113","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-024-04938-w","article-title":"Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105502_bib114","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","article-title":"The role of exosomes in immunopathology and potential therapeutic implications","volume":"22","author":"Wang","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-025-07454-x","article-title":"CAR-T therapy dilemma and innovative design strategies for next generation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105502_bib116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","article-title":"Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell","volume":"20","author":"Ward","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105502_bib117","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40981-020-00339-2","article-title":"A case of successful anesthetic management in a patient with Trousseau\u2019s syndrome who underwent surgery for malignant ovarian tumor","volume":"6","author":"Watanabe","year":"2020","journal-title":"JA Clin. Rep."},{"key":"10.1016\/j.critrevonc.2026.105502_bib118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/jcrt.jcrt_1031_23","article-title":"Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"20","author":"Yang","year":"2024","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.critrevonc.2026.105502_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108278","article-title":"PPAR\u03b1 Inhibition Overcomes tumor-derived exosomal lipid-induced dendritic cell dysfunction","volume":"33","author":"Yin","year":"2020","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105502_bib120","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood.2023021166","article-title":"Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation","volume":"142","author":"Yong","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105502_bib121","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/ncomms4591","article-title":"Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen","volume":"5","author":"Yoshioka","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105502_bib122","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41698-024-00574-1","article-title":"Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFN\u03b1-TYK2-STAT-HSPA5 axis","volume":"8","author":"Zeng","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105502_bib123","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-010-0836-y","article-title":"Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells","volume":"59","author":"Zhang","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105502_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70283","article-title":"Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR-T-Cell Therapy","volume":"13","author":"Zhang","year":"2024","journal-title":"Cancer Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:50:37Z","timestamp":1787107837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":124,"alternative-id":["S1040842826003896"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105502","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105502"}}